TABLETTE MIT SEPARATEM BINDEMITTEL UND ERYTHRITOL

European patent · EP3541359 · In force

Register entry

Publication number
EP3541359
Application number
EP17783711
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 13, 2017
Published
Sep 25, 2019
Granted
Jan 27, 2021
Protection ends at the latest
Oct 12, 2037
Next annual fee due
Oct 31, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 9/20 (2006.01)
A61K 47/26 (2006.01)
A61K 31/00 (2006.01)
Priority
WO PCT/DK2016/050377 18.11.2016
US 201615356175 18.11.2016
PCT application
PCT/DK2017/050342 13.10.2017
PCT publication
WO2018/091050 24.05.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. May 10, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 10.05.2023

  5. Nov 17, 2022

    Change

    Published in Swissreg on 17.11.2022

  6. Dec 8, 2021

    Change

    Published in Swissreg on 08.12.2021

  7. Feb 17, 2021

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 17.02.2021

  8. Jan 27, 2021

    Granted

    Published in Swissreg on 27.01.2021

Parties

Holder

Fertin Pharma A/S

Dandyvej 19, 7100 Vejle, DK

Agent

VALIPAT

c/o BOVARD LTD Optingenstrasse 16, 3013 Bern

Inventor

WITTORFF, Helle

7120 Vejle Øst, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.